https://www.selleckchem.com/products/AZD0530.html
Patients with cancer are at increased risk for unfavorable outcomes from COVID-19. Knowledge about the outcome determinants of severe acute respiratory syndrome coronavirus 2 infection in this population is essential for risk stratification and definition of appropriate management. Our objective was to evaluate prognostic factors for all-cause mortality in patients diagnosed with both cancer and COVID-19. All consecutive patients with cancer hospitalized at our institution with COVID-19 were included. Electronic medical records were rev
Like
Comment
Share
